Citation

BibTex format

@article{Le:2019:10.1136/bcr-2018-228251,
author = {Le, Goueff A and Peters, J and Willcocks, L and Jayne, D},
doi = {10.1136/bcr-2018-228251},
journal = {BMJ Case Reports},
pages = {e228251--e228251},
title = {Visual loss in giant cell arteritis 3 weeks after steroid initiation},
url = {http://dx.doi.org/10.1136/bcr-2018-228251},
volume = {12},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Giant cell arteritis (GCA) is the most common vasculitis in adults and blindness is a common complication if left untreated. Oral glucocorticoids are the mainstay of treatment and if started promptly, loss of vision can usually be prevented. We present the case of a 77-year-old man who developed irreversible bilateral blindness after a confirmed diagnosis of GCA and oral steroid treatment. The roles of diagnostic delay, steroid dosing, significance of visual symptoms at diagnosis and after commencing oral glucocorticoids, and interpretation of ophthalmological signs are reviewed.
AU  - Le,Goueff A
AU  - Peters,J
AU  - Willcocks,L
AU  - Jayne,D
DO  - 10.1136/bcr-2018-228251
EP  - 228251
PY  - 2019///
SN  - 1757-790X
SP  - 228251
TI  - Visual loss in giant cell arteritis 3 weeks after steroid initiation
T2  - BMJ Case Reports
UR  - http://dx.doi.org/10.1136/bcr-2018-228251
UR  - https://casereports.bmj.com/content/12/3/e228251
VL  - 12
ER  -
Download